Interference of drospirenone with the screening tests for primary aldosteronism.
Donckier
J E
JE
D000328:Adult; D000736:Androstenes / Q000009:adverse effects* / Q000494:pharmacology*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000139:chemically induced* / Q000175:diagnosis*; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology*; D012084:Renin-Angiotensin System / Q000187:drug effects*
D000736:Androstenes; D000451:Mineralocorticoid Receptor Antagonists; C534342:drospirenone and ethinyl estradiol combination; D004997:Ethinyl Estradiol; C035144:drospirenone